EyePoint Pharmaceuticals Inc (EYPT) is a pharmaceutical company that specializes in developing and commercializing innovative ophthalmic products. As an investor, it is important to analyze the technical indicators of EYPT to make informed decisions. Technical analysis involves studying historical price and volume data to identify patterns and trends that can help predict future price movements.

One popular technical indicator is the Relative Strength Index (RSI), which measures the speed and change of price movements. A high RSI value suggests that the stock is overbought and may experience a price correction, while a low RSI value indicates oversold conditions. It is important to consider the RSI in conjunction with other indicators to get a more comprehensive view of the stock's potential.

EyePoint Pharmaceuticals  (EYPT) Technical Analysis

EyePoint Pharmaceuticals Inc (EYPT) technical indicators, stock RSI, ADX, MACD, ROC, STOCHRSI, WILLR. Technical analysis rating for EyePoint Pharmaceuticals Inc (EYPT). Learn about INSTRUMENT_TECHNICAL_ANALYSIS.

EyePoint Pharmaceuticals Inc (EYPT) Technical Analysis

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, engages in developing and commercializing therapeutics to enhance the lives of patients with serious eye disorders in the United States, China, and the United Kingdom. Its commercial products include YUTIQ for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU for the treatment of postoperative inflammation. The company's pipeline leverages its Durasert technology for sustained intraocular drug delivery, including EYP-1901, an investigational sustained delivery intravitreal treatment that is in Phase 2 clinical trials. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

EyePoint Pharmaceuticals 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	39.39	Neutral	24.3%
auto_graphMACD	-8.72	Neutral	-17.8%
auto_graphCCI	-140.35	Buy	23.6%
auto_graphADX	15.13	Neutral	27.0%
auto_graphATR	14.79	Buy	-
auto_graphWILLR	-68.89	Neutral	10.7%
auto_graphROC	-11.87	Neutral	33.9%
auto_graphSTOCHRSI	0.00	Buy	124.5%

Buy	3	-62.50%
Hold	5	-37.50%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

EyePoint Pharmaceuticals (EYPT) Technical Analysis

Keep an eye on EyePoint Pharmaceuticals

Frequently Asked Questions

What are the technical signals for EyePoint Pharmaceuticals (EYPT) stock based on the last 30 days?

Take Your Investments to a Whole New Level